Pharmacology & Mechanisms

Lipolysis

The metabolic process of breaking down stored triglycerides into free fatty acids and glycerol for energy use. Stimulated by growth hormone, GH fragments (AOD-9604), and GLP-1 receptor agonists.

Frequently Asked Questions

What is Lipolysis?

The metabolic process of breaking down stored triglycerides into free fatty acids and glycerol for energy use. Stimulated by growth hormone, GH fragments (AOD-9604), and GLP-1 receptor agonists.

Why is Lipolysis important in peptide research?

Lipolysis is a key pharmacological concept that determines how peptides interact with the body. Understanding this term helps practitioners optimize dosing protocols, predict therapeutic outcomes, and minimize side effects.

Related Terms

Lipogenesis

The metabolic process of synthesizing fatty acids and triglycerides for fat storage. Occurs primarily in the liver and adipose tissue. Inhibited by peptides like AOD-9604 and growth hormone fragments.

Metabolic syndrome

A cluster of conditions including central obesity, elevated blood sugar, high blood pressure, and abnormal cholesterol that together increase the risk of heart disease, stroke, and type 2 diabetes.

Related Peptide Profiles

AOD-9604

A synthetic fragment of human growth hormone (amino acids 177–191) that stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 or insulin.

Semaglutide

A GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic) and weight management (Wegovy). Reduces appetite and slows gastric emptying.

← Back to full glossary